Financial Review: InterCure (NASDAQ:INCR) vs. Envista (NYSE:NVST)

InterCure (NASDAQ:INCR) and Envista (NYSE:NVST) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for InterCure and Envista, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InterCure	1	0	0	0	1.00
Envista	0	9	6	0	2.40

Envista has a consensus price target of $28.83, indicating a potential upside of 23.63%. Given Envista’s stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than InterCure.

Insider and Institutional Ownership

8.3% of InterCure shares are owned by institutional investors. 0.2% of InterCure shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

InterCure has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Envista has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Profitability

This table compares InterCure and Envista’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InterCure	N/A	N/A	N/A
Envista	2.41%	7.11%	3.91%

Valuation and Earnings

This table compares InterCure and Envista”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InterCure	$78.47 million	0.65	-$10.37 million	$0.03	30.93
Envista	$2.72 billion	1.40	$47.00 million	$0.41	56.89

Envista has higher revenue and earnings than InterCure. InterCure is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Summary

Envista beats InterCure on 12 of the 14 factors compared between the two stocks.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.